Trevi Therapeutics, Inc.
TRVIBiotechnology
$13.56−1.81%As of Oct 30vs prior close
- Market cap
- $1.9B
- P/E (TTM)
- –
- From 52W high
- −30.46%
- EPS (LTM)
- -$0.34
Nomior Score
59
Steady ProfileTop 28% of the scored universe
Growth—
Quality56
Value60
Momentum63
Resilience53
Connections
Who owns it
2funds, 1 tracked portfolio